ESC 365 - Great Debate: metformin – still first-line therapy in type 2 diabetes and heart disease? – discussion.

ESC Premium Access

Great Debate: metformin – still first-line therapy in type 2 diabetes and heart disease? – discussion.

Session: Great Debate: metformin – still first-line therapy in type 2 diabetes and heart disease?

Topic: Risk Factors and Prevention

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

2 more presentations in this session

Metformin: the cornerstone of antidiabetic therapy in 2021: pro.

Speaker: Professor J. Petrie (Glasgow, GB)

Metformin: the cornerstone of antidiabetic therapy in 2021: con.

Speaker: Professor N. Marx (Aachen, DE)

Access the full session

Great Debate: metformin – still first-line therapy in type 2 diabetes and heart disease?

Speakers: Professor J. Petrie, Professor N. Marx

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources